Insider Selling: NIOX Group (LON:NIOX) Insider Sells 4,512 Shares of Stock

NIOX Group Plc (LON:NIOX) insider Nicholas Mills sold 4,512 shares of the stock in a transaction that occurred on Tuesday, October 27th. The stock was sold at an average price of GBX 80, for a total value of £3,609.60.

NIOX Group Price Performance

Shares of NIOX traded up GBX 0.20 during trading hours on Wednesday, hitting GBX 64.60. 281,066 shares of the stock were exchanged, compared to its average volume of 902,221. The company has a debt-to-equity ratio of 1.06, a quick ratio of 1.94 and a current ratio of 4.60. NIOX Group Plc has a 12-month low of GBX 53.84 and a 12-month high of GBX 80. The company has a market cap of £271.88 million, a price-to-earnings ratio of 39.63 and a beta of 0.92. The stock’s 50-day moving average price is GBX 67.34 and its two-hundred day moving average price is GBX 63.13.

NIOX Group (LON:NIOX) last announced its quarterly earnings data on Wednesday, September 30th. The company reported GBX 1.41 EPS for the quarter. NIOX Group had a return on equity of 10.01% and a net margin of 14.74%. Research analysts expect that NIOX Group Plc will post 1.17 earnings per share for the current year.

NIOX Group Company Profile

NIOX Group plc is a medical technology company focused on improving the lives of millions of people suffering from respiratory health issues globally. NIOX develops and markets innovative, non-invasive diagnostic products for chronic airway diseases, primarily asthma and COPD. Its lead product, NIOX VERO®, enables the accurate measurement of fractional exhaled nitric oxide (FeNO), an established biomarker for airway inflammation, supporting better diagnosis, monitoring and management of asthma and COPD in clinical and research settings.

Headquartered in the UK and listed on the London Stock Exchange (ticker: NIOX), the company operates internationally, serving healthcare professionals in over 50 countries.